Inhibitors of αLβ2 mediated cell adhesion
US6897225B1 · kind B1 · utility
10Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2000 |
| Grant date | May 24, 2005 |
| Priority date | — |
| Expiry date | Oct 19, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a compound of the following formula: or a pharmaceutically acceptable salt thereof. Also disclosed are compositions containing the compound and methods of preparing and using the compounds. The compounds of the invention are useful in treating αLβ2 adhesion mediated conditions in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.